Acquisition Fit NovelCath is the integrated brand for Cardea Catheter Innovations within Cirtec Medical, signaling a strategic shift toward a broader interventional device focus and potential cross-sell opportunities across braided and coiled catheter shafts, steerable sheaths, balloons and microcatheters.

Interventional Focus The company targets structural heart, electrophysiology, and neurovascular applications, presenting entry points for sales discussions with teams serving these segments, including hospitals and ambulatory surgery centers adopting advanced catheter technologies.

Financial Footprint Current revenue range of 1M to 10M indicates a midsize instrument supplier with growth potential; suitable for strategic partnerships, co-development programs, and pilot projects to expand customer base within Cirtec’s ecosystem.

Engineering Expertise Specialization in braided and coiled reinforced catheter shafts, complex steerable designs, and advanced balloons and microcatheters suggests upsell opportunities for durability, precision, and customization in high-performance devices for complex procedures.

Operational Footprint San Jose, CA location and 501-1000 employees indicate a regional R&D and manufacturing node with capability for collaboration on gap-fill development, regulatory-ready prototypes, and scalable manufacturing to support larger OEM partnerships.